Los Angeles Capital Management
WVE icon

Los Angeles Capital Management’s Wave Life Sciences WVE Stock Holding History

Los Angeles Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,461
Closed -$303K – 1246
2024
Q4 		$303K Buy
+24,461
New +$327K ﹤0.01% 929
2021
Q2 		– Sell
-13,050
Closed -$73K – 1686
2021
Q1 		$73K Buy
+13,050
New +$125K ﹤0.01% 1569
2019
Q2 		– Sell
-6,330
Closed -$246K – 1439
2019
Q1 		$246K Buy
+6,330
New +$257K ﹤0.01% 1258

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Los Angeles Capital Management's WVE Position: Q1 2025 in Review

Los Angeles Capital Management sold out of Wave Life Sciences (WVE) in Q1 2025, closing a stake of 24,461 shares — an estimated $303K sold.

Los Angeles Capital Management first reported a position in WVE in Q1 2019 and held it in 3 quarters. The position peaked at $303K in Q4 2024. 196 funds tracked by Wall St. Rank hold WVE as of Q1 2025.

  • Los Angeles Capital Management reported no remaining Wave Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Los Angeles Capital Management sold 24,461 Wave Life Sciences shares in Q1 2025, an estimated $303K.
  • Los Angeles Capital Management first reported a position in Wave Life Sciences in Q1 2019 and held it in 3 quarters.
  • Los Angeles Capital Management's Wave Life Sciences position peaked at $303K in Q4 2024.
  • 196 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2025.

Based on Los Angeles Capital Management's 13F filing for Q1 2025, filed 5 May 2025.